RPG Life Sciences Files SEBI Compliance Certificate for Q4FY26
RPG Life Sciences Limited received a compliance certificate from its Registrar and Transfer Agents, MUFG Intime India Private Limited. The certificate confirms adherence to SEBI (Depositories and Participants) Regulations, 2018 for the quarter ending March 31, 2026, regarding the dematerialisation of securities.
This is a standard regulatory filing that confirms compliance with SEBI regulations. It does not introduce any new material information that is likely to affect the company's stock price or operations.
The announcement is a routine compliance filing and does not contain any new financial information or strategic updates that would impact the company's valuation or outlook.
RPG Life Sciences Limited has submitted a certificate confirming compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate, dated April 03, 2026, was issued by MUFG Intime India Private Limited, the company's Registrar and Transfer Agents.
The certificate confirms that securities received from depository participants for dematerialisation during the quarter ended March 31, 2026, were processed and confirmed with the depositories. It also states that the dematerialised securities are listed on the stock exchanges where the company's securities are already listed. Furthermore, the security certificates received for dematerialisation were mutilated and cancelled after verification, and the depositories' names have been substituted in the register of members within the prescribed timelines.
The company has requested that this information be taken on record.
What to do with a filing like this
RPG Life Sciences Limited filed this with the NSE as a statutory disclosure, categorised under sebi compliance filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by RPG Life Sciences Limited. Read the original for the full detail.